Myriad Genetics, Inc. (FRA:MYD)
Germany · Delayed Price · Currency is EUR 5.55
-0.05 (-0.89%)
At close: Jan 9, 2026
Myriad Genetics Employees
Myriad Genetics had 2,700 employees as of December 31, 2024. The number of employees did not change compared to the previous year.
Employees
2,700
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
€260,520
Profits / Employee
€126,425
Market Cap
527.29M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 2,700 | 0 | - |
| Dec 31, 2023 | 2,700 | 100 | 3.85% |
| Dec 31, 2022 | 2,600 | 200 | 8.33% |
| Dec 31, 2021 | 2,400 | -300 | -11.11% |
| Dec 31, 2020 | 2,700 | 0 | - |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Siemens Aktiengesellschaft | 317,562 |
| Deutsche Telekom AG | 198,194 |
| Mercedes-Benz Group AG | 175,264 |
| Bayerische Motoren Werke Aktiengesellschaft | 159,104 |
| Allianz SE | 156,626 |
| SAP SE | 109,121 |
| Siemens Energy AG | 98,995 |
| Deutsche Bank Aktiengesellschaft | 89,753 |
Myriad Genetics News
- 12 days ago - Should Myriad Genetics Stock Stay in Your Portfolio Right Now? - Nasdaq
- 24 days ago - Zydus Lifesciences signs exclusive agreement with Myriad Genetics to launch advanced cancer genomic tests in India - Business Upturn
- 6 weeks ago - Myriad Genetics partners to use AI to measure breast cancer risk - Seeking Alpha
- 6 weeks ago - Clairity, Myriad Genetics, and MagView Launch the First Integrated AI and Genetic Risk Platform for Personalized Breast Health - GlobeNewsWire
- 2 months ago - Myriad Genetics to Participate in Upcoming Investor Healthcare Conferences - GlobeNewsWire
- 2 months ago - Myriad Genetics (MYGN) Broadens MyRisk Cancer Test with New Gene Inclusions - GuruFocus
- 2 months ago - Myriad Genetics Adds 15 Clinically Actionable Genes to MyRisk Hereditary Cancer Test to Support Evolving Clinical Needs - Wallstreet:Online
- 2 months ago - Vanguard Group Inc Reduces Stake in Myriad Genetics Inc - GuruFocus